Generalforsamling i Novo Nordisk A/S

February 26, 2004 06:00 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

Vi vedlægger indkaldelse med dagsorden med uddybning og motivering af forslagene (se pdf-filen).

For yderligere information kontakt:

Medier:	Investorer:

Mike Rulis	Peter Haahr
Tlf. (direkte): 4442 3573	Tlf. (direkte): 4442 1207

	Palle Holm Olesen
	Tlf. (direkte): 4442 6175

Fondsbørsmeddelelse nr. 17 ( 2004)

Attachments

Læs i PDF format

Læs i PDF format...

Recommended Reading

September 16, 2026 08:00 ET | Source: Novo Nordisk A/S

Novo and Anthropic will collaborate to advance drug discovery with Claude

Novo and Anthropic collaboration will help Novo accelerate the development of new medicines and advance AI-driven software development
Read More
September 16, 2026 03:00 ET | Source: Novo Nordisk A/S

Novo to share real-world and clinical data including Wegovy® pill, and cardiometabolic pipeline progress with next-generation amylin treatments at EASD 2026

Novo to share real-world and clinical data including Wegovy® pill and cardiometabolic pipeline progress with next-generation amylin treatments at EASD
Read More